Relationship Between Serum Potassium, Magnesium, and Calcium in Patients Receiving Cetuximab Therapy

Abstract

We identified patients with unresectable advanced or recurrent colorectal cancer and head and neck cancer, treated with Cmab from September 2012 to September 2020 using medical records. We excluded patients with a history of anticancer drug therapy. Patients were administered 4 regimens: Cmab monotherapy; SOX+Cmab therapy, which included S-1, oxaliplatin, and Cmab; CBDCA+5-FU+Cmab, which included carboplatin, 5-fluorouracil, and Cmab; PCE therapy, which included paclitaxel, carboplatin,